Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease.

BACKGROUND AND AIMS Antibodies directed against oligomannose sequences alpha-1,3 Man (alpha-1,2 Man alpha-1,2 Man)(n) (n = 1 or 2), termed anti-Saccharomyces cerevisiae antibodies (ASCAs) are markers of Crohn's disease (CD). S. cerevisiae mannan, which expresses these haptens, is used to detect ASCA, but the exact immunogen for ASCA is unknown. Structural and genetic studies have shown that Candida albicans produces mannosyltransferase enzymes that can synthesize S cerevisiae oligomannose sequences depending on growth conditions. This study investigated whether C. albicans could act as an immunogen for ASCA. METHODS Sequential sera were collected from patients with CD, systemic candidiasis, and rabbits infected with C. albicans. Antibodies were purified by using chemically synthesized (Sigma) ASCA major epitopes. These affinity-purified antibodies and lectins were then used to analyze the expression of ASCA epitopes on molecular extracts and cell walls of C. albicans and S cerevisiae grown in various conditions. RESULTS In humans and rabbits, generation of ASCA was shown to be associated with the generation of anti-C. albicans antibodies resulting specifically from infection. By using affinity-purified antibodies, C. albicans was shown to express ASCA epitopes on mannoproteins similar to those of S. cerevisiae. By changing the growth conditions, C. albicans mannan was also able to mimic S. cerevisiae mannan in its ability to detect ASCA associated with CD. This overexpression of ASCA epitopes was achieved when C. albicans grew in human tissues. CONCLUSIONS C. albicans is one of several immunogens for ASCA and may be at the origin of an aberrant immune response in CD.

[1]  D. Teitelbaum,et al.  Colostomy: formation and closure , 2006 .

[2]  Alistair J. P. Brown,et al.  Outer Chain N-Glycans Are Required for Cell Wall Integrity and Virulence of Candida albicans* , 2006, Journal of Biological Chemistry.

[3]  A. Duhamel,et al.  Anti-Saccharomyces cerevisiae antibodies in twins with inflammatory bowel disease , 2005, Gut.

[4]  F. Klis,et al.  CandidaDB: a genome database for Candida albicans pathogenomics , 2004, Nucleic Acids Res..

[5]  G. Strecker,et al.  Inactivation of CaMIT1 Inhibits Candida albicans Phospholipomannan β-Mannosylation, Reduces Virulence, and Alters Cell Wall Protein β-Mannosylation* , 2004, Journal of Biological Chemistry.

[6]  J. Sung,et al.  A Prospective Comparative Study of ASCA and pANCA in Chinese and Caucasian IBD Patients , 2004, The American Journal of Gastroenterology.

[7]  M. Whiteway,et al.  Candida morphogenesis and host-pathogen interactions. , 2004, Current opinion in microbiology.

[8]  S. Targan,et al.  Bacterial flagellin is a dominant antigen in Crohn disease , 2004 .

[9]  G. Pawelec.  Extrathymic T-cell differentiation in vitro , 2004, Nature Reviews Immunology.

[10]  F. Seibold,et al.  Immune Sensitization to Yeast Antigens in ASCA-positive Patients with Crohn’s Disease , 2004, Inflammatory bowel diseases.

[11]  J. Sanderson,et al.  Serum and salivary IgA antibody responses to Saccharomyces cerevisiae, Candida albicans and Streptococcus mutans in orofacial granulomatosis and Crohn's disease , 2004, Clinical and experimental immunology.

[12]  W. Mow,et al.  Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. , 2004, Gastroenterology.

[13]  D. Poulain,et al.  Increased Sensitivity of Mannanemia Detection Tests by Joint Detection of α- and β-Linked Oligomannosides during Experimental and Human Systemic Candidiasis , 2004, Journal of Clinical Microbiology.

[14]  A. Sharpe,et al.  B7/CD28-Dependent CD4+CD25+ Regulatory T Cells Are Essential Components of the Memory-Protective Immunity to Candida albicans1 , 2002, The Journal of Immunology.

[15]  A. Bonnin,et al.  Combined detection of mannanaemia and antimannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. , 2002, Journal of medical microbiology.

[16]  G. Norman.  Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease , 2001 .

[17]  P. Rutgeerts,et al.  Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease , 2001, American Journal of Gastroenterology.

[18]  M. Scheurlen,et al.  Anti-Saccharomyces cerevisiae Antibodies in Inflammatory Bowel Disease: a Family Study , 2001, Scandinavian journal of gastroenterology.

[19]  I. Fajardy,et al.  Mother to child transmission of anti- S cerevisiae mannan antibodies (ASCA) in non-IBD families , 2000, Gut.

[20]  S. Targan,et al.  Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics , 2000, Gut.

[21]  D. McClish,et al.  Nosocomial bloodstream infections in United States hospitals: a three-year analysis. , 1999, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  M. J. Gradwell,et al.  Characterization of oligosaccharides from an antigenic mannan of Saccharomyces cerevisiae , 1998, Glycoconjugate Journal.

[23]  O. Goulet,et al.  Anti-Saccharomyces cerevisiae mannan antibodies in familial crohn’s disease , 1998 .

[24]  S. Targan,et al.  Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role , 1998, Gut.

[25]  G. Kunze,et al.  Humoral immune response to a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae is common in man. , 1998, Immunology letters.

[26]  T. Kanbe,et al.  Biochemical characterization of Candida albicans epitopes that can elicit protective and nonprotective antibodies , 1997, Infection and immunity.

[27]  S. Suzuki,et al.  Structure and antigenicity of the mannans of Candida famata and Candida saitoana: comparative study with the mannan of Candida guilliermondii. , 1996, Archives of biochemistry and biophysics.

[28]  H. Oyamada,et al.  Identification of the antigenic determinants of factors 8, 9, and 34 of genus Candida , 1996, FEBS letters.

[29]  P. Jacquinot,et al.  Specific antibody response to oligomannosidic epitopes in Crohn's disease , 1996, Clinical and diagnostic laboratory immunology.

[30]  V. Loppinet,et al.  Structure of the phosphopeptidomannans from flocculent and non-flocculent yeast Kluyveromyces lactis. , 1996, Carbohydrate research.

[31]  R. Wenzel.  Nosocomial candidemia: risk factors and attributable mortality. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[32]  J. Wieruszeski,et al.  Beta-1,2-linked oligomannosides from Candida albicans act as signals for tumor necrosis factor alpha production , 1995, Infection and immunity.

[33]  S. Suzuki,et al.  Structural modification of cell wall mannans of Candida albicans serotype A strains grown in yeast extract-Sabouraud liquid medium under acidic conditions , 1994, Infection and immunity.

[34]  D. V. van Thiel,et al.  Candida carriage in the alimentary tract of liver transplant candidates. , 1994, Transplantation.

[35]  P. Jacquinot,et al.  Mapping of Candida albicans oligomannosidic epitopes by using monoclonal antibodies , 1992, Infection and immunity.

[36]  J. Michalski,et al.  Evaluation of an enzyme immunoassay using neoglycolipids constructed fromCandida albicans oligomannosides to define the specificity of anti-mannan antibodies , 1992, European Journal of Clinical Microbiology and Infectious Diseases.

[37]  J. Main,et al.  Antigenic heterogeneity of strains of Saccharomyces cerevisiae and Candida albicans recognised by serum antibodies from patients with Crohn's disease. , 1992, FEMS microbiology immunology.

[38]  I. Goldstein,et al.  Interactions of five D-mannose-specific lectins with a series of synthetic branched trisaccharides. , 1991, Carbohydrate research.

[39]  S. Allan,et al.  Identification of a 200-kDa glycoprotein antigen of Saccharomyces cerevisiae. , 1991, Immunology letters.

[40]  J. Main,et al.  Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. , 1990, Gut.

[41]  M. Kerr,et al.  Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. , 1988, BMJ.

[42]  F. Smith,et al.  A Colorimetric Method for the Determination of Sugars , 1951, Nature.

[43]  C. Pennington,et al.  The effect of dietary yeast on the activity of stable chronic Crohn's disease. , 1992, Scandinavian journal of gastroenterology.

[44]  F. Odds,et al.  Candida and candidosis , 1979 .